HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...
For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...
While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...
WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...
PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...
Tariffs and significant US manufacturing investments complicate ROI calculations and increase operational costs, challenging ...
Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...
In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing ...
Global pharmaceutical production surged in 2025 due to tariff-driven front-loading but is expected to slow as trade ...
In an agreement that seemingly bodes well for the flow of pharmaceuticals between the two regions, the EU and India on Monday agreed to a sweeping free trade agreement that the European bloc has ...
SAN DIEGO, CA - January 27, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough ...
THE Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results